M&A / Deals Merck buys life sciences firm Bio-Techne in $11.3bn deal PharmaphorumMerck KGaA is poised to increase the size of its life sciences business with an $11.3 billion deal to acquire rival Bio-techne.Read full story pharminent June 25, 2026 (Last updated: June 26, 2026) Pharmaphorum Merck KGaA is poised to increase the size of its life sciences business with an $11.3 billion deal to acquire rival Bio-techne. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Ionis secures market expansion for Tryngolza as FDA clears severe hypertriglyceridemia useNext: Ionis grants Recordati rights to zilganersen for Alexander disease Related Stories M&A / Deals Supernus and Indivior merge to create CNS mega-company with 11 approved drugs pharminent August 3, 2026 M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026
